THE REDUCTION OF ANTITUMOR DIAZIRIDINYL BENZOQUINONES

被引:39
作者
BUTLER, J
HOEY, BM
LEA, JS
机构
关键词
D O I
10.1016/0304-4165(87)90103-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:144 / 149
页数:6
相关论文
共 24 条
[1]  
BACHUR NR, 1978, CANCER RES, V38, P1745
[2]  
BASRA J, 1985, ANTI-CANCER DRUG DES, V1, P45
[3]  
Bender J F, 1983, Invest New Drugs, V1, P71
[4]  
BOSANQUET AG, 1985, INVEST NEW DRUG, V3, P43
[5]  
BUTLER J, 1986, Journal of Free Radicals in Biology and Medicine, V2, P77, DOI 10.1016/0748-5514(86)90127-3
[6]  
BUTLER J, 1987, IN PRESS BR J CANCER
[7]   POTENTIAL CENTRAL NERVOUS-SYSTEM ANTITUMOR AGENTS - AZIRIDINYLBENZOQUINONES .2. [J].
CHOU, F ;
KHAN, AH ;
DRISCOLL, JS .
JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (11) :1302-1308
[8]   A PHASE-II TRIAL OF 2,5-DIAZIRIDINYL3,6-BIS(CARBOETHOXYAMINO)1,4-BENZOQUINONE(AZQ,NSC-182986) IN RECURRENT PRIMARY BRAIN-TUMORS [J].
FEUN, LG ;
YUNG, WKA ;
LEAVENS, ME ;
BURGESS, MA ;
OBBENS, EA ;
BEDIKIAN, AY ;
SAVARAJ, N ;
STEWART, DJ ;
BENJAMIN, RS ;
FIELDS, WS ;
BODEY, GP .
JOURNAL OF NEURO-ONCOLOGY, 1984, 2 (01) :13-17
[9]  
GUTIERREZ PL, 1982, CANCER TREAT REP, V66, P339
[10]   EFFECTS OF ASCORBIC-ACID ON BIOLOGICALLY OBTAINED DIAZIQUONE FREE-RADICALS [J].
GUTIERREZ, PL ;
EGORIN, MJ ;
DAVIS, TA ;
BACHUR, NR .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (13) :2394-2397